Usrm Announces Us Stem Cell Clinic Expansion Of Products And Services | Latest News RSS feed

Usrm Announces Us Stem Cell Clinic Expansion Of Products And Services - Latest News


USRM announces U.S. Stem Cell Clinic Expansion of Products and Services

Dec. 6, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc., a leader in regenerative medicine products and services, today announced its three partially ... and tissue bank products -- U.S. Stem Cell Clinic is ... read more

U.S. Stem Cell, Inc. Announces Clinical Expansion in US Market

Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the opening of another regenerative clinic using ... read more

Adipocell™ Stem Cell Therapy Shows Safety In A Wide Variety of Applications

MIAMI, Dec. 1, 2017 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM ... Clinic) includes the development of proprietary cell therapy products, as well as revenue generating physician and patient-based ... read more

Looking for another news?


RoosterBio and GenCure expand collaboration to provide end-to-end solutions for hMSC-based therapies

RoosterBio’s extensive experience in producing high-quality, clinically relevant hMSCs for product ... stem cells. “The progress being made through the MTEC collaboration, and now our expanded focus w... read more


Novo Nordisk to build manufacturing plant in California to develop stem cell-based therapies

Novo Nordisk announced the establishment of a manufacturing site in Fremont, California, US to develop and produce ... enabling the future expansion of Novo Nordisk's stem cell research portfolio into ... read more

USRM Hires Senior VP of US & International Sales

11, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced ... exp... read more

The 4 Healthcare Stocks To Watch On Monday

The Canadian medical cannabis clinic ... Products Administration ("NMPA") (formerly, the China FDA) approval of Melphalan Hydrochloride For Injection (EVOMELA®), for use as a high-dose conditioning tr... read more

TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial

TiGenix (OTC:TGXSF) - listed on Euronext Brussels under ticker "TIG" - is a leading European stem cell company. The small-cap biotech has already one product on the market (ChondroCelect, an autologou... read more

NYSCF Announces Expansion Of Scientific Leadership Team

"I am pleased and excited to join a world-leading independent stem cell research institute, and am eager to help advance stem cell therapies into the clinic under the visionary ... biotech, blood prod... read more

BioLife: Groundfloor Opportunity In Regenerative Medicine

The first step they took was a $5M expansion ... announced growth strategy to invest in companies and technologies that also supply the cell and gene therapy industry with innovative, highly valued so... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us